Methods To identify candidate biomarkers we compared 46 breath samples from cirrhosis
patients and 42 from controls. Collection and analysis used Breath Biopsy OMNI™ …

Early diagnosis of liver cirrhosis may prevent progression and development of
complications. Liver biopsy is the current standard, but is invasive and associated with …

METHODS: We compared the exhaled breath of 40 controls, 32 cirrhotic patients, and 12
cirrhotic patients with HCC using the Breath Biopsy platform. Breath samples were analyzed …

Background & aims Analysis of volatile organic compounds (VOCs) in exhaled
breath,'volatomics', provides opportunities for non-invasive biomarker discovery and novel …

Hepatocellular carcinoma (HCC) and secondary liver tumors, such as colorectal cancer liver
metastases are significant contributors to the overall burden of cancer‐related morality …

The diagnosis of asymptomatic cirrhosis in patients with liver disease is of importance to
start screening for complications in due time. Liver biopsy is neither sensitive nor practical …

Liver disease is characterized by breath exhalation of peculiar volatile organic compounds
(VOCs). Thanks to the availability of sensitive technologies for breath analysis, this empiric …

Background The burden of liver disease in the UK has risen dramatically and there is a need
for improved diagnostics. Aims To determine which breath volatiles are associated with the …

The gold standard method for chronic liver diseases diagnosis and staging remains liver
biopsy, despite the spread of less invasive surrogate modalities based on imaging and …

Background: Cirrhosis detection in primary care relies on low-performing biomarkers.
Consequently, up to 75% of subjects with cirrhosis receive their first diagnosis with …